Zhang Wenliang, Shi Hongshun, Zhang Mingming, Liu Bin, Mao Shuai, Li Li, Tong Fang, Liu Guoliang, Yang Shulan, Wang Haihe
Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, CPZN 510080, People's Republic of China; Translational Medicine Centre, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, CPZN 510080, People's Republic of China.
Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, CPZN 510080, People's Republic of China.
Int J Biochem Cell Biol. 2016 Apr;73:127-136. doi: 10.1016/j.biocel.2016.02.009. Epub 2016 Feb 12.
Accumulating evidences indicate that poly C binding protein (PCBP1) is downregulated in various carcinomas as a tumor suppressor, but the underlying mechanism in suppression of tumorigenesis still remains elusive. Here, we found that PCBP1 overexpression attenuates tumor cell growth upon serum-free starvation. Notably, the autophagic degradation inhibitor, chloroquine, could mimic this suppressive effect in tumor cell growth. Autophagy analyses demonstrated that PCBP1 overexpression blocked autophagic flux of tumor cells under starvation conditions, while PCBP1 downregulation in turn refueled this autophagic flux, protecting cells from death. Mechanistically, PCBP1 overexpression attenuated microtubule-associated protein Light chain 3 (LC3B) mRNA stability to repress LC3B expression, resulting in the autophagy inhibition. Consequently, PCBP1 overexpression strongly triggered the caspase 3 and 8-mediated apoptosis of tumor cells and downregulated anti-apoptotic Bcl-2 expression upon starvation, which could be further synergized by autophagic inhibitor, indicating that PCBP1 not only inhibits tumor cell autophagy, but also renders them to apoptosis. Taken together, our results uncovered a novel mechanism of PCBP1 in repressing autophagy-mediated cell survival and indicated that inhibition of tumor cell autophagy by PCBP1 upregulation or with autophagic inhibitors could be an effective therapeutical strategy to colon and ovary tumors with low PCBP1 expression.
越来越多的证据表明,多聚胞嘧啶结合蛋白(PCBP1)作为一种肿瘤抑制因子在多种癌症中表达下调,但其抑制肿瘤发生的潜在机制仍不清楚。在此,我们发现PCBP1过表达可在无血清饥饿条件下减弱肿瘤细胞的生长。值得注意的是,自噬降解抑制剂氯喹可模拟这种对肿瘤细胞生长的抑制作用。自噬分析表明,PCBP1过表达在饥饿条件下阻断了肿瘤细胞的自噬流,而PCBP1下调则反过来增强了这种自噬流,保护细胞免于死亡。机制上,PCBP1过表达减弱了微管相关蛋白轻链3(LC3B)mRNA的稳定性以抑制LC3B表达,从而导致自噬抑制。因此,PCBP1过表达在饥饿时强烈触发肿瘤细胞的半胱天冬酶3和8介导的凋亡,并下调抗凋亡蛋白Bcl-2的表达,自噬抑制剂可进一步增强这种作用,这表明PCBP1不仅抑制肿瘤细胞自噬,还使其发生凋亡。综上所述,我们的结果揭示了PCBP1抑制自噬介导的细胞存活的新机制,并表明通过上调PCBP1或使用自噬抑制剂抑制肿瘤细胞自噬可能是治疗PCBP1低表达的结肠癌和卵巢癌的有效策略。